Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Urol. 2017 Oct 21;199(4):921–926. doi: 10.1016/j.juro.2017.10.027

Table 1.

Patient characteristics by preoperative eGFR

Overall
(N = 1928)
eGFR≥60
(N = 1351)
eGFR<60
(N = 577)
p-value* Orignal MSKCC study
(N = 572)
Age at surgery, median (IQR) 64 (54, 72) 61 (53, 69) 70 (61, 77) <.001 61 (53, 69)
Tumor size (cm), median (IQR) 6.9 (4.8, 9.5) 6.8 (4.7, 9.4) 7.1 (5.0, 9.8) 0.528 7.7 (5.5, 10.4)
Sex, N (%) 0.731
 Female 683 (35.4) 482 (35.7) 201 (34.8) 185 (32.3)
 Male 1245 (64.6) 869 (64.3) 376 (65.2) 387 (67.7)
Race, N (%) 0.414
 Black 117 (6.1) 93 (6.9) 24 (4.2) 37 (6.5)
 Other 54 (2.8) 36 (2.7) 18 (3.1) 29 (5.1)
 White 1757 (91.1) 1222 (90.5) 535 (92.7) 506 (88.5)
Diabetes, N (%) <.001
 No 1480 (76.8) 1062 (78.6) 418 (72.4) 476 (83.2)
 Yes 448 (23.2) 289 (21.4) 159 (27.6) 96 (16.8)
Hypertension, N (%) <.001
 No 692 (35.9) 551 (40.8) 141 (24.4) 215 (37.6)
 Yes 1236 (64.1) 800 (59.2) 436 (75.6) 357 (62.4)
*

p-value from logistic regression adjusted for study center